Featured Research

from universities, journals, and other organizations

Link between missing DNA, birth defects confirmed

Date:
March 11, 2014
Source:
University of Pennsylvania
Summary:
The genetic basis for a particular human syndrome that involves cleft palate, epilepsy and respiratory difficulties has been identified by researchers. Better understanding of these genes could help guide treatments for related conditions. "Epilepsy and cleft palate affect tens of thousands of children in the U.S. alone each year," authors said, "and respiratory failure is a particular problem in premature and low birth weight babies. Finding the causative genes for these conditions could have some very clinically important implications."

In 2010, scientists in Italy reported that a woman and her daughter showed a puzzling array of disabilities, including epilepsy and cleft palate. The mother had previously lost a 15-day-old son to respiratory failure, and the research team noted that the mother and daughter were missing a large chunk of DNA on their X chromosome. But the researchers were unable to definitively show that the problems were tied to that genetic deletion.

Now a team from the University of Pennsylvania and The Children's Hospital of Philadelphia has confirmed that those patients' ailments resulted from the genetic anomaly. Creating mice that lacked the same region of DNA, the Penn and CHOP researchers showed that these animals suffered the same problems that afflicted the mother, daughter and son -- cleft palate, epilepsy and respiratory difficulties, a condition called human Xq22.1 deletion syndrome. And, by clarifying the syndrome's genetic basis, the researchers have laid the foundation for identifying the underlying molecular mechanism of these troubles and potentially treating them at their biological root.

"This study has demonstrated that deleting this region in mice causes them to respond like humans with the same deletion," said P. Jeremy Wang, senior author on the study and professor in the Penn School of Veterinary Medicine's Department of Animal Biology. "Now that we have a mouse model, we can dissect and try to genetically pinpoint which genes are responsible."

Wang co-led the study with his postdoctoral researcher Jian Zhou. Additional coauthors included Penn Vet's N. Adrian Leu and CHOP's Ethan Goldberg, Lei Zhou and Douglas Coulter.

The study appears in the journal Human Molecular Genetics.

To investigate the effects of missing this portion of DNA, more than 1 million base pairs long, the Penn team crossed existing mice that had particular deletions in their DNA to create a mouse that lacked the entire stretch that the human patients were missing. They quickly observed that all male mice died at birth due to respiratory failure. Females, who would have one normal X chromosome and one X chromosome with this missing stretch of genetic material, survived but had varying degrees of symptoms including epilepsy, cleft palate and other developmental problems.

"We believe this is because of skewed X chromosome inactivation," Wang said. "In females one of the X chromosomes' expression is randomly 'silenced' so that males and females have an equal dosage of genetic material from this sex chromosome under normal circumstances. In this case, if more female cells silence the X chromosome that has the deletion, the effects of the syndrome won't be as severe."

To narrow down which part of the deleted genetic material was responsible for the observed birth defects, the researchers genetically engineered one type of mice that lacked the first two-thirds of the original genetic deletion and another type that lacked the final third.

Unexpectedly, the mice lacking the two-thirds of the region on the X chromosome, which included 17 genes, did not display any respiratory failure, cleft palate or epilepsy.

"These mice were fine," Wang said. "It was very surprising to us that deleting this many genes on the X chromosome did not cause apparent problems for the mice."

This was not the case for the mice missing the last 350 kilobase pairs of the region of interest. These mice had the same suite of problems as mice missing the entire region: males died after birth and females had cleft palates, higher rates of death soon after birth, developmental delays and had seizures.

After ruling out the genes in this smaller region that have no equivalent in humans, the researchers were left with only four genes. All four belong to the same family of genes and encode proteins that are involved in cellular signaling.

"These proteins are involved in the neuronal circuitry and activity of neurotransmitters," Wang said. "That is probably why we see that females lacking one copy of these X-linked genes have epilepsy."

Wang and colleagues plan to continue studying these four genes to determine which lead to the developmental problems such as cleft palate and epilepsy when they are missing. The information gained from this and future studies could inform prenatal testing, Wang said, giving doctors advance warning to treat possible respiratory or other problems in newborns.

Understanding how the lack of these genes leads to epilepsy could also help guide treatments for the condition.

"Epilepsy and cleft palate affect tens of thousands of children in the U.S. alone each year," Wang said, "and respiratory failure is a particular problem in premature and low birth weight babies. Finding the causative genes for these conditions could have some very clinically important implications."


Story Source:

The above story is based on materials provided by University of Pennsylvania. Note: Materials may be edited for content and length.


Journal Reference:

  1. J. Zhou, E. M. Goldberg, N. A. Leu, L. Zhou, D. A. Coulter, P. J. Wang. Respiratory failure, cleft palate and epilepsy in the mouse model of human Xq22.1 deletion syndrome. Human Molecular Genetics, 2014; DOI: 10.1093/hmg/ddu095

Cite This Page:

University of Pennsylvania. "Link between missing DNA, birth defects confirmed." ScienceDaily. ScienceDaily, 11 March 2014. <www.sciencedaily.com/releases/2014/03/140311151951.htm>.
University of Pennsylvania. (2014, March 11). Link between missing DNA, birth defects confirmed. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2014/03/140311151951.htm
University of Pennsylvania. "Link between missing DNA, birth defects confirmed." ScienceDaily. www.sciencedaily.com/releases/2014/03/140311151951.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins